|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Module
6 |
|
Advertising
and the Pharmaceutical Industry |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Another major advertiser is the pharmaceutical industry which
advertises the use of ads for treating a range of problems, particularly
given the fact that Congress, spurred on by industry lobbying, forced
the Food and Drug Administration to loosen controls on drug advertising.
While ads do have to mention negative side effects, they often do
not have to go into detail about those side effects. Much of the
cost of this advertising has resulted in the industry refusing to
lower the costs of drugs in the United States, which, unlike other
countries such as Canada, does not bargain directly with the industry
to set drug prices. These ads are effective in that various studies
find that people are increasingly more likely to ask doctors about
these drugs.
PBS Now program with Bill Moyers: A
Brief History of Drug Advertising |
One doctor, Michael
Wilkes, of the University of California, Davis, Medical School,
noted that these “direct-to-consumer” ads attempt to
work around the doctor by fostering a belief that patients have
certain health problems that need to be treated: |
In both cases, the goal is to get patients to seek attention
for conditions that they previously considered benign or natural.
The ads also seek to make their product sound remark able compared
to other existing treatments. The goal is to get patients using
one drug to switch to another…
Patients ask about ads that encourage them to focus on trivial
somatic complaints or cosmetic anomalies, leading to unhealthy
bodily preoccupation and inappropriate use of health services.
The ads often lead to physician-patient conflict as a result of
the doctor’s unwillingness to prescribe an unnecessary or
costly drug. The patient leaves the office dissatisfied and disrespected.
|
Belkin, L. (2001). Prime
Time Pushers. Mother Jones Magazine |
|
|